Drug Name |
Pazopanib
|
||
Synonyms |
Pazopanib; Pazopanibum
|
||
Drug Type |
Small molecular drug
|
||
Company |
NA
|
||
Summary |
Pazopanib is an antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy.
|
![]() |
Formula |
C21H23N7O2S
|
Canonical SMILES |
CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
|
|
InChI |
1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)
|
|
InChIKey |
CUIHSIWYWATEQL-UHFFFAOYSA-N
|
|
CAS Number | CAS 444731-52-6 | |
TTD ID | NA | |
DrugBank ID | DB06589 | |
PubChem Compound ID | 10113978 | |
PubChem Substance ID | ||
ChEBI ID | CHEBI:71219 | |
ADReCS Drug ID | NA |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |